Almus

What Almus does

Almus is a private-label brand of generic medicines launched in the United Kingdom in 2003 and now established across five European markets: the UK, France, Italy, Spain, and Portugal. The brand is owned by Alliance UniChem IP Limited and operated by Alliance Healthcare (Distribution) Limited, which sits within the Cencora (formerly AmerisourceBergen) group. Almus does not manufacture its own products; instead, it sources a wide and growing portfolio of generic medicines from multiple manufacturers, including some of the world's largest generics companies, and distributes them through wholesalers to community and hospital pharmacies.

The company's principal point of differentiation is patient-safe packaging design, using color-coded packaging to help pharmacists and healthcare professionals quickly identify active ingredients and dosages, an approach that has won multiple user-focused design awards in European markets. Almus operates country-specific websites and dedicated pharmacovigilance and medical information contact points in each market, with regional offices in Chessington (UK), Gennevilliers (France), and El Prat de Llobregat (Barcelona, Spain). Distribution in Italy is handled through an exclusive arrangement with Skills in Healthcare Italia.

Almus generates revenue through the sale of generic pharmaceutical products at negotiated wholesale pricing through pharmacy channels, with no public pricing disclosure. Its end customers are community and hospital pharmacies and the healthcare professionals who dispense its products, and its operational model leverages the Alliance Healthcare wholesale network to achieve high service levels and broad shelf availability across European markets. The company is not separately listed and does not disclose brand-level financials.

Name

Almus

Legal name

Alliance Healthcare (Distribution) Limited

Website

https://almus.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

10,001+ employees

Short description

Almus is a multi-country European private-label brand of generic medicines, operating in the UK, France, Italy, Spain, and Portugal under the Alliance Healthcare (Cencora) umbrella, distributing through wholesalers to community and hospital pharmacies with a packaging-led differentiation strategy.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834)

akta.pro industry

PRIMARYHLAIABAL

Generic Hospital & Institutional Products

Healthcare & Life Sciences/Pharmaceuticals/Generic Pharmaceuticals

Keywords

• Generic medicines
• Pharmaceutical distribution
• Patient-safe packaging
• Wholesale pharmacy supply
• Therapeutic categories

Headquarters

HQ city

Chessington

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Generic medicines sales: Almus generates revenue through the sale of generic pharmaceutical products. The medicines are produced by multiple manufacturers including some of the world's largest generics companies. Products are distributed through wholesalers to pharmacies.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Core offering

Almus manufactures and distributes a wide range of generic pharmaceutical medicines across multiple therapeutic categories in Europe. Products are produced by multiple manufacturers including some of the world's largest generics companies, then sold through wholesaler distribution networks to community and hospital pharmacies. The brand differentiates through patient-safe, award-winning packaging design intended to aid dispensing accuracy.

Product overview

Almus is a multi-country portfolio of generic medicine brands offering high-quality generic medicines across a wide and growing range of therapeutic categories. The company operates through regional subsidiaries in France, Italy, Spain, and the UK, each providing locally-appropriate product ranges. The products are manufactured by multiple producers, including some of the world's largest generics companies. Almus positions itself on patient-safe packaging design and operational efficiency in pharmacy dispensing. The portfolio includes the core Almus Generic Medicines range supplemented by pharmacovigilance support services across all markets.

Differentiator

Problem solved

Functional benefit

Products and services

• Almus Generic Medicines A comprehensive range of high-quality generic medicines spanning a wide and growing set of therapeutic categories, produced by multiple manufacturers including some of the world's largest generics companies. Distributed through wholesalers to community and hospital pharmacies for dispensing to patients.
• Almus Pharmacovigilance Services Adverse event reporting and medical information request services for Almus products, with dedicated contact points and email addresses across the European markets where Almus operates.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Three partnerships are on record, tiered core.

• Skills in Healthcare ItaliacoreChannel Partner/ Reseller/ DistributorSkills in Healthcare Italia holds exclusive distribution rights for Almus products in Italy. The partnership enables local presence and regulatory compliance for generic medicines in the Italian market.
• World's largest generics companies (manufacturers)coreOEM/ Whitelabel/ Licensing PartnerAlmus products are produced by multiple manufacturers including some of the world's largest generics companies. This partnership model enables wide therapeutic coverage and supply reliability.
• Alliance Healthcare (Distribution) LimitedcoreOthersParent company providing distribution infrastructure, governance policies, and operational support. Almus is operated under the Alliance Healthcare / Cencora umbrella with aligned code of conduct and supplier code of conduct policies.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Others

• Cencora: Parent company of Alliance Healthcare (which operates Almus). While not a peer in the competitive sense, Cencora provides the distribution infrastructure and governance framework within which Almus operates, making it the most relevant ecosystem participant.

Regional players

• Phoenix Group: European pharmaceutical wholesale and distribution group serving pharmacies across multiple EU countries. Comparable to Almus's distribution model (wholesaler-to-pharmacy) though focused on distribution rather than brand ownership.

Direct peers

• Krka: Slovenian-headquartered generics company with strong Central and Eastern European presence and growing Western European footprint. Comparable to Almus in offering multi-category generic medicines through pharmacy channels.
• Viatris: Global generics and specialty pharma company formed from Mylan and Upjohn. Operates an extensive European generics portfolio across multiple therapeutic categories, comparable to Almus's multi-country generic medicines range.
• Stada Arzneimittel: European-focused generics and consumer healthcare company with strong presence in Germany, UK, and other Western European markets. Highly comparable to Almus as a pan-European generics brand distributed through pharmacy channels.
• Teva Pharmaceutical Industries: World's largest generics manufacturer with a broad portfolio across therapeutic categories. Most directly comparable to Almus in terms of multi-category generic medicines distributed through European pharmacy channels.
• Aurobindo Pharma: Indian-headquartered global generics manufacturer with substantial European presence. Comparable as a multi-category generics producer serving European pharmacy distribution channels.
• Zentiva: European generics manufacturer with operations across multiple EU markets including UK, France, Italy, and Spain. Directly comparable to Almus's geographic footprint and broad-category generics strategy.
• Sandoz: Novartis's generics and biosimilars division, offering a broad portfolio of off-patent medicines across Europe and globally. Closely comparable to Almus in serving European pharmacy channels with multi-category generics.

Broad incumbents

• McKesson Corporation: Global pharmaceutical distribution giant with private-label generic programs across multiple geographies. Comparable as a broad incumbent in the pharma distribution and generic medicines value chain.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/almus-limited

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Almus